Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BX-1 for Spasticity in Multiple Sclerosis
NCT03756974Phase 3Completed
- Sponsor
- Bionorica
- Start
- Feb 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of dronabinol in multiple sclerosis (MS), sponsored by Bionorica. Started Feb 2019; status: completed.
02
Drugs
dronabinol
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT03756974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03756974.